712 related articles for article (PubMed ID: 26168936)
21. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
[TBL] [Abstract][Full Text] [Related]
22. Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.
Tomasik J; Harrison SJ; Rustogi N; Olmert T; Barton-Owen G; Han SYS; Cooper JD; Eljasz P; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
JAMA Psychiatry; 2024 Jan; 81(1):101-106. PubMed ID: 37878349
[TBL] [Abstract][Full Text] [Related]
23. Metabolomic analysis to detect urinary molecular changes associated with bipolar depression.
Ren Y; Chen ZZ; Sun XL; Duan HJ; Tian JS; Wang JY; Yang H
Neurosci Lett; 2021 Jan; 742():135515. PubMed ID: 33227370
[TBL] [Abstract][Full Text] [Related]
24. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
25. Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach.
Caboni P; Meloni A; Lussu M; Carta E; Barberini L; Noto A; Deiana SF; Mereu R; Ragusa A; Paoletti AM; Melis GB; Fanos V; Atzori L
J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():4-12. PubMed ID: 25284171
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
[TBL] [Abstract][Full Text] [Related]
27. Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents.
Yin B; Cai Y; Teng T; Wang X; Liu X; Li X; Wang J; Wu H; He Y; Ren F; Kou T; Zhu ZJ; Zhou X
Transl Psychiatry; 2024 Mar; 14(1):163. PubMed ID: 38531835
[TBL] [Abstract][Full Text] [Related]
28. GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age.
Hou L; Wei X; Zhuo Y; Qin L; Yang F; Zhang L; Song X
Aging (Albany NY); 2018 Sep; 10(9):2252-2265. PubMed ID: 30178754
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
[TBL] [Abstract][Full Text] [Related]
30. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
31. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
32. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
33. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China.
Xiang YT; Zhang L; Wang G; Hu C; Ungvari GS; Dickerson FB; Kilbourne AM; Si TM; Fang YR; Lu Z; Yang HC; Lai KY; Lee EH; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
Bipolar Disord; 2013 Mar; 15(2):199-205. PubMed ID: 23437963
[TBL] [Abstract][Full Text] [Related]
34. Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis.
Sun XL; Ma LN; Chen ZZ; Xiong YB; Jia J; Wang Y; Ren Y
Front Psychiatry; 2023; 14():1251955. PubMed ID: 37736060
[TBL] [Abstract][Full Text] [Related]
35. A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.
Zhang W; Zhang XA
Cell Biochem Biophys; 2015 Jul; 72(3):661-7. PubMed ID: 27352185
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing medication-free subjects with unipolar disorder from subjects with bipolar disorder: state matters.
Rive MM; Redlich R; Schmaal L; Marquand AF; Dannlowski U; Grotegerd D; Veltman DJ; Schene AH; Ruhé HG
Bipolar Disord; 2016 Nov; 18(7):612-623. PubMed ID: 27870505
[TBL] [Abstract][Full Text] [Related]
37. Age-specific urinary metabolite signatures and functions in patients with major depressive disorder.
Chen JJ; Xie J; Li WW; Bai SJ; Wang W; Zheng P; Xie P
Aging (Albany NY); 2019 Sep; 11(17):6626-6637. PubMed ID: 31493765
[TBL] [Abstract][Full Text] [Related]
38. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder.
van der Voort TY; Seldenrijk A; van Meijel B; Goossens PJ; Beekman AT; Penninx BW; Kupka RW
J Clin Psychiatry; 2015 Jun; 76(6):e809-14. PubMed ID: 26132690
[TBL] [Abstract][Full Text] [Related]
39. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
[TBL] [Abstract][Full Text] [Related]
40. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
